To the full analysis
Buyback calculator for Cardinal Health
Cardinal Health stock: key metrics
CAHCardinal Health had an operating margin of 1% and a return on invested capital (ROIC) of 13.6% in fiscal 2026.
Margins show how much of revenue is left over, returns on capital how hard the invested money works.
Daily figure as of 13 Nov 2026
Margins
- Gross margin
- Operating margin
- Net margin
Figures as a table
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| 2007 | 6.0% | 1.6% | no data |
| 2008 | 6.4% | 1.6% | 1.5% |
| 2009 | 5.8% | 1.3% | 1.2% |
| 2010 | 3.8% | 1.3% | 0.7% |
| 2011 | 4.1% | 1.5% | 0.9% |
| 2012 | 4.2% | 1.7% | 1.0% |
| 2013 | 4.9% | 1.0% | 0.3% |
| 2014 | 5.7% | 2.1% | 1.3% |
| 2015 | 5.6% | 2.1% | 1.2% |
| 2016 | 5.4% | 2.0% | 1.2% |
| 2017 | 5.0% | 1.6% | 1.0% |
| 2018 | 5.2% | 0.1% | 0.2% |
| 2019 | 4.7% | 1.4% | 0.9% |
| 2020 | 4.5% | −2.7% | −2.4% |
| 2021 | 4.2% | 0.3% | 0.4% |
| 2022 | 3.6% | −0.3% | −0.5% |
| 2023 | 3.4% | 0.4% | 0.2% |
| 2024 | 3.3% | 0.5% | 0.4% |
| 2025 | 3.7% | 1.0% | 0.7% |
| 2026 | 3.8% | 1.0% | 0.7% |
Returns on capital
- ROE
- ROIC
- ROA
Figures as a table
| Year | ROE | ROIC | ROA |
|---|---|---|---|
| 2007 | no data | 9.8% | no data |
| 2008 | 16.8% | 9.7% | 5.5% |
| 2009 | 13.2% | 8.4% | 4.6% |
| 2010 | 12.2% | 8.3% | 3.2% |
| 2011 | 16.4% | 17.4% | 4.2% |
| 2012 | 17.1% | 17.0% | 4.4% |
| 2013 | 5.6% | 6.7% | 1.3% |
| 2014 | 18.2% | 15.8% | 4.5% |
| 2015 | 19.4% | 18.2% | 4.0% |
| 2016 | 21.8% | 18.3% | 4.2% |
| 2017 | 18.9% | 14.2% | 3.2% |
| 2018 | 4.2% | 0.8% | 0.6% |
| 2019 | 21.5% | 12.8% | 3.3% |
| 2020 | −100.0% | −36.7% | −9.1% |
| 2021 | 34.1% | 8.7% | 1.4% |
| 2022 | 132.3% | −3.0% | −2.1% |
| 2023 | −11.2% | 3.1% | 0.8% |
| 2024 | −26.5% | 8.6% | 1.9% |
| 2025 | −56.1% | 13.6% | 2.9% |
| 2026 | −59.5% | 13.6% | 3.0% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2026, period end 30 Jun 2026
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 31 Jan 2024)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.